Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Prostate Cancer

Free Subscription Articles published in Eur Urol Retrieve available abstracts of 335 articles: HTML format

Single Articles

April 2008
1. SCIARRA A , Salciccia S, Panebianco V
   Proton Spectroscopic and Dynamic Contrast-Enhanced Magnetic Resonance: A Modern Approach in Prostate Cancer Imaging.
   Eur Urol. 2008;.
   PubMed     Related articles   
   
   
   
2. GONTERO P , Joniau S, Van Poppel H
   Radical Prostatectomy for PSA>/=100ng/ml Prostate Cancer.
   Eur Urol. 2008;.
   PubMed     Related articles   
   
   
   
3. GOSSELAAR C , Roobol MJ, Roemeling S, Schroder FH, et al
   The Role of the Digital Rectal Examination in Subsequent Screening Visits in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam.
   Eur Urol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. WOLTERS T , Schroder FH
   Reply from Authors re: Martha K. Terris. Editorial Comment on: Is Prostate-Specific Antigen Velocity Selective for Clinically Significant Prostate Cancer In Screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
   Eur Urol. 2008;.
   PubMed     Related articles   
   
   
   
5. YOSSEPOWITCH O
   Digital Rectal Examination Remains an Important Screening Tool for Prostate Cancer.
   Eur Urol. 2008;.
   PubMed     Related articles   
   
   
   
6. BRAUSI M , Rizzi F, Bettuzzi S
   Chemoprevention of Human Prostate Cancer by Green Tea Catechins: Two Years Later. A Follow-up Update.
   Eur Urol. 2008;.
   PubMed     Related articles   
   
   
   
7. CHUN FK , Briganti A
   Editorial Comment on: Preliminary Results of a Novel Method to Estimate the Probability of Prostate Cancer in Men with Elevated Serum PSA Values.
   Eur Urol. 2008;.
   PubMed     Related articles   
   
   
   
8. SPYROPOULOS E , Dellis AE
   Preliminary Results of a Novel Method to Estimate the Probability of Prostate Cancer in Men with Elevated Serum PSA Values.
   Eur Urol. 2008;.
   PubMed     Related articles   
   
   
   
9. CIATTO S
   Editorial Comment on: Digital Rectal Examination and the Diagnosis of Prostate Cancer-a Study Based on 8 Years and Three Screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam.
   Eur Urol. 2008;.
   PubMed     Related articles   
   
   
   
10. GOSSELAAR C , Roobol MJ, van den Bergh RC, Wolters T, et al
    Digital Rectal Examination and the Diagnosis of Prostate Cancer-a Study Based on 8 Years and Three Screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. GOMELLA LG
    Re: identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911.
    Eur Urol. 2008;53:855-6.
    PubMed     Related articles    Abstract available
    
    
    March 2008
12. ADOLFSSON J
    The Management of Category T1a-T1b (Incidental) Prostate Cancer: Can We Predict Who Needs Treatment?
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
13. PINKAWA M , Gagel B, Piroth MD, Fischedick K, et al
    Erectile Dysfunction After External Beam Radiotherapy for Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. BRIGANTI A
    Editorial Comment on: Erectile Dysfunction After External Beam Radiotherapy for Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
15. MEULEMAN E
    Editorial Comment on: Erectile Dysfunction After External Beam Radiotherapy for Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
16. KIROLLOS M
    Re: Axel Heidenreich, Gunnar Aus, Michel Bolla et al. EAU Guidelines on Prostate Cancer. Eur Urol 2008;53:68-80.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
17. TERRIS MK
    Editorial Comment on: Is Prostate-Specific Antigen Velocity Selective for Clinically Significant Prostate Cancer In Screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
18. WOLTERS T , Roobol MJ, Bangma CH, Schroder FH, et al
    Is Prostate-Specific Antigen Velocity Selective for Clinically Significant Prostate Cancer in Screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. ALCARAZ A
    Management of the Hormone Sensitivity of Prostate Cancer: Where Are We Now?
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
20. IRANI J
    Rebuttal from Authors re: Antonio Alcaraz. Management of the Hormone Sensitivity of Prostate Cancer: Where Are We Now? Eur Urol: In Press. doi:10.1016/j.eururo.2008.02.042.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
21. CAGIANNOS I
    Editorial Comment on: Evaluation of Prostate Cancer Detection with Ultrasound Real-Time Elastography: A Comparison with Step Section Pathological Analysis After Radical Prostatectomy.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
22. SALOMON G , Kollerman J, Thederan I, Chun FK, et al
    Evaluation of Prostate Cancer Detection with Ultrasound Real-Time Elastography: A Comparison with Step Section Pathological Analysis after Radical Prostatectomy.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. SALONIA A
    Editorial Comment on: Preoperative Serum Sex Hormone-Binding Globulin as a Predictive Marker for Extraprostatic Extension of Tumor in Patients with Clinically Localized Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
24. LEE SE , Chung JS, Han BK, Park CS, et al
    Preoperative Serum Sex Hormone-Binding Globulin as a Predictive Marker for Extraprostatic Extension of Tumor in Patients with Clinically Localized Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. VAN AS NJ , Norman AR, Thomas K, Khoo VS, et al
    Predicting the Probability of Deferred Radical Treatment for Localised Prostate Cancer Managed by Active Surveillance.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. ADOLFSSON J
    Editorial Comment on: Predicting the Probability of Deferred Radical Treatment for Localised Prostate Cancer Managed by Active Surveillance.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
27. DA POZZO LF
    Editorial Comment on: The Feasibility of Prostate Cancer Detection by Triple Spectroscopy.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
28. SALOMON G , Hess T, Erbersdobler A, Eichelberg C, et al
    The Feasibility of Prostate Cancer Detection by Triple Spectroscopy.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
29. ALBRECHT W
    Editorial Comment on: Continuous versus Six Months a Year Maximal Androgen Blockade in the Management of Prostate Cancer: A Randomised Study.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
30. IRANI J , Celhay O, Hubert J, Bladou F, et al
    Continuous versus Six Months a Year Maximal Androgen Blockade in the Management of Prostate Cancer: A Randomised Study.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
31. GRAEFEN M
    Words of wisdom. Re: Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911.
    Eur Urol. 2008;53:664-5.
    PubMed     Related articles   
    
    
    February 2008
32. CAPITANIO U , Scattoni V, Freschi M, Briganti A, et al
    Radical Prostatectomy for Incidental (Stage T1a-T1b) Prostate Cancer: Analysis of Predictors for Residual Disease and Biochemical Recurrence.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
33. BOLLA M
    Clinical Stage T3 Prostate Cancer: The Added Value of Three-Dimensional Conformal/Intensity-Modulated External-Beam Radiotherapy.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
34. 
    The Motion: All Men Over the Age of 50 Should be Encouraged to Take a 5alpha-Reductase Inhibitor to Prevent Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
35. NUMAO N , Kawakami S
    Reply to Rafael Boscolo-Berto, Antonio Galfano and Massimo Iafrate's Letter to the Editor re: Noburu Numao, Satoru Kawakami, Minato Yokoyama et al. Improved Accuracy in Predicting the Presence of Gleason Pattern 4/5 Prostate Cancer by Three-Dimensional 2
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
36. BOSCOLO-BERTO R , Galfano A, Iafrate M
    Re: Noburu Numao, Satoru Kawakami, Minato Yokoyama et al. Improved Accuracy in Predicting the Presence of Gleason Pattern 4/5 Prostate Cancer by Three-Dimensional 26-Core Systematic Biopsy. Eur Urol 2007;52:1663-9.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
37. ZELEFSKY M
    Rebuttal from Authors re: Michel Bolla. Clinical Stage T3 Prostate Cancer: The Added Value of Three-Dimensional Conformal/Intensity-Modulated External-Beam Radiotherapy. Eur Urol. In Press. doi:10.1016/j.eururo.2008.02.004.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
38. WHELAN P
    Endocrine Events in Prostate Cancer: A Paradigm Shift in Our Understanding?
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
39. FRISK J , Spetz AC, Hjertberg H, Petersson B, et al
    Two Modes of Acupuncture as a Treatment for Hot Flushes in Men with Prostate Cancer-A Prospective Multicenter Study with Long-Term Follow-Up.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
40. STEPHANE O
    Editorial Comment on: Combination of Bevacizumab and Docetaxel in Docetaxel-Pretreated Hormone-Refractory Prostate Cancer: A Phase 2 Study.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
41. DI LORENZO G , Figg WD, Fossa SD, Mirone V, et al
    Combination of Bevacizumab and Docetaxel in Docetaxel-Pretreated Hormone-Refractory Prostate Cancer: A Phase 2 Study.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
42. SHAW G , Price AM, Ktori E, Bisson I, et al
    Hedgehog Signalling in Androgen Independent Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
43. CHEN M , Buttyan R
    Editorial Comment on: Hedgehog Signalling in Androgen Independent Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
44. SHARIAT SF , Karakiewicz PI
    Perspectives on Prostate Cancer Biomarkers.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
45. MONTIRONI R
    Words of wisdom. Re: Radial distance of extraprostatic extension measured by ocular micrometer is an independent predictor of prostate-specific antigen recurrence. A new proposal for the substaging of pT3a prostate cancer .
    Eur Urol. 2008;53:449-50.
    PubMed     Related articles   
    
    
    
46. MONGIAT-ARTUS P
    Words of wisdom. Re: Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911 .
    Eur Urol. 2008;53:448-9.
    PubMed     Related articles   
    
    
    January 2008
47. SCHRODER FH
    Progress in Understanding Androgen-Independent Prostate Cancer (AIPC): A Review of Potential Endocrine-Mediated Mechanisms.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
48. STEUBER T , O'Brien MF, Lilja H
    Serum Markers for Prostate Cancer: A Rational Approach to the Literature.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
49. VAN LEENDERS GJ
    Editorial Comment on: Expression and Prognostic Relevance of Annexin A3 in Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
50. HARKONEN P
    Editorial Comment on: Expression and Prognostic Relevance of Annexin A3 in Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
51. KOLLERMANN J , Schlomm T, Bang H, Schwall GP, et al
    Expression and Prognostic Relevance of Annexin A3 in Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
52. KATTAN MW
    Editorial Comment on: Development, Validation, and Head-to-Head Comparison of Logistic Regression-Based Nomograms and Artificial Neural Network Models Predicting Prostate Cancer on Initial Extended Biopsy.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
53. KAWAKAMI S , Numao N, Okubo Y, Koga F, et al
    Development, Validation, and Head-to-Head Comparison of Logistic Regression-Based Nomograms and Artificial Neural Network Models Predicting Prostate Cancer on Initial Extended Biopsy.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
54. WHELAN P
    Editorial Comment on: Cardiovascular Mortality and Duration of Androgen Deprivation for Locally Advanced Prostate Cancer: Analysis of RTOG 92-02.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
55. EFSTATHIOU JA , Bae K, Shipley WU, Hanks GE, et al
    Cardiovascular Mortality and Duration of Androgen Deprivation for Locally Advanced Prostate Cancer: Analysis of RTOG 92-02.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
56. DOEHN C
    Immunotherapy of Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
57. KIESSLING A , Fussel S, Wehner R, Bachmann M, et al
    Re: Christian Doehn. Immunotherapy for Prostate Cancer. Eur Urol 2008. In press. doi:10.1016/j.eururo.2007.12.038.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
58. SCHRODER FH
    Words of wisdom. Re: duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer.
    Eur Urol. 2008;53:210-1.
    PubMed     Related articles   
    
    
    
59. KATZ MD , Kibel AS
    Words of wisdom. Re: EPCA-2: a highly specific serum marker for prostate cancer.
    Eur Urol. 2008;53:210.
    PubMed     Related articles   
    
    
    
60. KLEIN EA , Kattan M, Stephenson A, Vickers A, et al
    How many lymphadenectomies does it take to cure one patient?
    Eur Urol. 2008;53:13-5.
    PubMed     Related articles   
    
    
    
61. MATTEI A , Fuechsel FG, Bhatta Dhar N, Warncke SH, et al
    The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study.
    Eur Urol. 2008;53:118-25.
    PubMed     Related articles    Abstract available
    
    
    
62. SOLOWAY MS
    Thromboembolism prophylaxis and total prostatectomy: is pharmacologic therapy required?
    Eur Urol. 2008;53:21-3.
    PubMed     Related articles   
    
    
    December 2007
63. SCIARRA A , Panebianco V, Salciccia S, Osimani M, et al
    Role of Dynamic Contrast-Enhanced Magnetic Resonance (MR) Imaging and Proton MR Spectroscopic Imaging in the Detection of Local Recurrence after Radical Prostatectomy for Prostate Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
64. HARA N
    Editorial Comment on: Role of Dynamic Contrast-Enhanced Magnetic Resonance (MR) Imaging and Proton MR Spectroscopic Imaging in the Detection of Local Recurrence after Radical Prostatectomy for Prostate Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
65. FUTTERER JJ , Barentsz JO
    Editorial Comment on: Role of Dynamic Contrast-Enhanced Magnetic Resonance (MR) Imaging and Proton MR Spectroscopic Imaging in the Detection of Local Recurrence after Radical Prostatectomy for Prostate Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
66. ZELEFSKY MJ , Yamada Y, Kollmeier MA, Shippy AM, et al
    Long-Term Outcome Following Three-Dimensional Conformal/Intensity-Modulated External-Beam Radiotherapy for Clinical Stage T3 Prostate Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
67. STUDER UE , Collette L, Whelan P, Albrecht W, et al
    Using PSA to Guide Timing of Androgen Deprivation in Patients with T0-4 N0-2 M0 Prostate Cancer not Suitable for Local Curative Treatment (EORTC 30891).
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
68. STANGELBERGER A , Schally AV, Djavan B
    New Treatment Approaches for Prostate Cancer Based on Peptide Analogues.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
69. BAMIAS A , Dimopoulos MA
    Editorial Comment on: New treatment approaches for prostate cancer based on peptide analogues.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
70. MCLEOD DG
    Editorial Comment on: New Treatment Approaches for Prostate Cancer Based on Peptide Analogues.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
71. KARAKIEWICZ PI , Suardi N, Shariat SF
    The Search for Better Prognostic Factors for Men Treated for Localized Prostate Cancer Continues.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
72. ROSARIO DJ , Lane JA, Metcalfe C, Catto JW, et al
    Contribution of a Single Repeat PSA Test to Prostate Cancer Risk Assessment: Experience from the ProtecT Study.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
73. SHARIAT SF , Karakiewicz PI
    Screening for Prostate Cancer in 2007: The PSA Era and its Challenges are not Over.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
74. SALONIA A
    Editorial Comment on: Validation of the Contemporary Epstein Criteria for Insignificant Prostate Cancer in European Men.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
75. LOPEZ-BELTRAN A , Montironi R
    Editorial Comment on: Validation of the Contemporary Epstein Criteria for Insignificant Prostate Cancer in European Men.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
76. JELDRES C , Suardi N, Walz J, Hutterer GC, et al
    Validation of the Contemporary Epstein Criteria for Insignificant Prostate Cancer in European Men.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
77. PARKER C
    Editorial comment on: Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy.
    Eur Urol. 2007;52:1651-2.
    PubMed     Related articles   
    
    
    
78. DE REIJKE TM
    Editorial comment on: Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy.
    Eur Urol. 2007;52:1650-1.
    PubMed     Related articles   
    
    
    
79. HURWITZ M
    Editorial comment on: Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution.
    Eur Urol. 2007;52:1661-2.
    PubMed     Related articles   
    
    
    
80. ALGABA F
    Words of wisdom. Re: The relationship between the extent of surgical margin positivity and prostate-specific antigen recurrence in radical prostatectomy specimens.
    Eur Urol. 2007;52:1796.
    PubMed     Related articles   
    
    
    
81. SCHRADER M , Miller K, Schostak M
    Re: Christian Barre. Open radical retropubic prostatectomy. Eur Urol 2007;52:71-80.
    Eur Urol. 2007;52:1802-3.
    PubMed     Related articles   
    
    
    November 2007
82. COOPER C
    Editorial Comment on: ADAM9 Expression is a Significant and Independent Prognostic Marker of PSA Relapse in Prostate Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
83. VALENTINI A , Bernardini S
    Editorial Comment on: ADAM9 Expression is a Significant and Independent Prognostic Marker of PSA Relapse in Prostate Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
84. FRITZSCHE FR , Jung M, Tolle A, Wild P, et al
    ADAM9 Expression is a Significant and Independent Prognostic Marker of PSA Relapse in Prostate Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
85. KIESSLING A , Fussel S, Wehner R, Bachmann M, et al
    Advances in Specific Immunotherapy for Prostate Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
86. LITWIN MS
    Editorial Comment on: High Provider Volume is Associated with Lower Rate of Secondary Therapies after Definitive Radiotherpy for Localized Prostate Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
87. YOSSEPOWITCH O
    Prostate Cancer in Men with Serum PSA of <4ng/ml: Under-diagnosed or Over-treated?
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
88. JELDRES C , Suardi N, Saad F, Montorsi F, et al
    High Provider Volume is Associated with Lower Rate of Secondary Therapies after Definitive Radiotherapy for Localized Prostate Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
89. ROACH M 3RD
    Editorial Comment on: High Provider Volume is Associated with Lower Rate of Secondary Therapies after Definitive Radiotherapy for Localized Prostate Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
90. THOMAS LN , Douglas RC, Lazier CB, Too CK, et al
    Type 1 and Type 2 5alpha-Reductase Expression in the Development and Progression of Prostate Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
91. BLANA A , Murat FJ, Walter B, Thuroff S, et al
    First Analysis of the Long-Term Results with Transrectal HIFU in Patients with Localised Prostate Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
92. EASTHAM JA
    Editorial Comment on: First Analysis of the Long-Term Results with Transrectal HIFU in Patients with Localized Prostate Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
93. FICARRA V , Novara G
    Editorial Comment on: First Analysis of the Long-Term Results with Transrectal HIFU in Patients with Localized Prostate Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
94. SCHRODER FH , Carter HB, Wolters T, van den Bergh RC, et al
    Early Detection of Prostate Cancer in 2007 Part 1: PSA and PSA Kinetics.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
95. MAFFEZZINI M
    High-Risk Prostate Cancer is Worth Further Risk Stratification.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
96. SCIARRA A
    Re: Serum bone turnover markers (PINP and ICTP) for the early detection of bone metastases in patients with prostate cancer: a longitudinal approach.
    Eur Urol. 2007;52:1531-2.
    PubMed     Related articles   
    
    
    
97. RAGHAVAN D
    Re: Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
    Eur Urol. 2007;52:1530-1.
    PubMed     Related articles   
    
    
    
98. BOORMANS JL , Schroder FH
    Re: Prostate cancer progression and survival in BRCA2 mutation carriers.
    Eur Urol. 2007;52:1529.
    PubMed     Related articles   
    
    
    
99. KATTAN MW
    Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin Tables) based on cases from 2000 to 2005.
    Eur Urol. 2007;52:1528.
    PubMed     Related articles   
    
    
    
100. HAMILTON RJ , Freedland SJ
     Combining prostate cancer clinical features more accurately predicts final pathologic stage than any single variable alone.
     Eur Urol. 2007;52:1380.
     PubMed     Related articles   
     
     
     
101. SCIARRA A
     Neuroendocrine differentiation in prostate adenocarcinoma.
     Eur Urol. 2007;52:1373.
     PubMed     Related articles   
     
     
     
102. GRAEFEN M
     Is the open retropubic radical prostatectomy dead?
     Eur Urol. 2007;52:1281-3.
     PubMed     Related articles   
     
     
     
103. GUILLONNEAU B
     Ceteris paribus and nomograms in medicine.
     Eur Urol. 2007;52:1287-9.
     PubMed     Related articles   
     
     
     
104. FICARRA V , Cavalleri S
     Editorial comment on: Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial.
     Eur Urol. 2007;52:1464.
     PubMed     Related articles   
     
     
     
105. AHYAI SA , Lehrich K, Kuntz RM
     Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial.
     Eur Urol. 2007;52:1456-63.
     PubMed     Related articles    Abstract available
     
     
     
106. GIANNARINI G
     Editorial comment on: Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial.
     Eur Urol. 2007;52:1463.
     PubMed     Related articles   
     
     
     
107. SIMONATO A , Gregori A, Lissiani A, Carmignani G, et al
     Two-stage transperineal management of posterior urethral strictures or bladder neck contractures associated with urinary incontinence after prostate surgery and endoscopic treatment failures.
     Eur Urol. 2007;52:1499-504.
     PubMed     Related articles    Abstract available
     
     
     
108. GALLINA A , Jeldres C, Chun FK, Shariat SF, et al
     Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.
     Eur Urol. 2007;52:1374-80.
     PubMed     Related articles    Abstract available
     
     
     October 2007
109. BARRY MJ
     Editorial Comment on: Poor Overall Survival in Septa- and Octogenarian Patients after Radical Prostatectomy and Radiotherapy for Prostate Cancer: A Population-Based Study of 6183 Men.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
110. JELDRES C , Suardi N, Walz J, Saad F, et al
     Poor Overall Survival in Septa- and Octogenarian Patients after Radical Prostatectomy and Radiotherapy for Prostate Cancer: A Population-Based Study of 6183 Men.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
111. AHYAI SA , Graefen M, Steuber T, Haese A, et al
     Contemporary Prostate Cancer Prevalence among T1c Biopsy-Referred Men with a Prostate-Specific Antigen Level </= 4.0ng per Milliliter.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
112. YOSSEPOWITCH O , Eggener SE, Serio AM, Carver BS, et al
     Secondary Therapy, Metastatic Progression, and Cancer-Specific Mortality in Men with Clinically High-Risk Prostate Cancer Treated with Radical Prostatectomy.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
113. VAN POPPEL H , Joniau S
     An Analysis of Radical Prostatectomy in Advanced Stage and High-Grade Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
114. SCHRODER FH
     Words of wisdom. Re: Statin drugs and risk of advanced prostate cancer (PC).
     Eur Urol. 2007;52:1258-9.
     PubMed     Related articles   
     
     
     
115. EGGENER S
     Editorial comment on: Methods of calculating prostate-specific antigen velocity.
     Eur Urol. 2007;52:1050-1.
     PubMed     Related articles   
     
     
     
116. AUS G
     Editorial comment on: Additional surgical intervention after radical prostatectomy, radiation therapy, androgen-deprivation therapy, or watchful waiting.
     Eur Urol. 2007;52:1043.
     PubMed     Related articles   
     
     
     
117. SCIARRA A , Di Silverio F, Salciccia S, Autran Gomez AM, et al
     Inflammation and chronic prostatic diseases: evidence for a link?
     Eur Urol. 2007;52:964-72.
     PubMed     Related articles    Abstract available
     
     
     
118. STENMAN UH
     Editorial comment on: Prostate-specific antigen improves the ability of clinical stage and biopsy gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
     Eur Urol. 2007;52:1074-5.
     PubMed     Related articles   
     
     
     
119. CHUN FK , Briganti A, Gallina A, Hutterer GC, et al
     Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
     Eur Urol. 2007;52:1067-74.
     PubMed     Related articles    Abstract available
     
     
     
120. CONNOLLY D , Black A, Murray LJ, Napolitano G, et al
     Methods of calculating prostate-specific antigen velocity.
     Eur Urol. 2007;52:1044-50.
     PubMed     Related articles    Abstract available
     
     
     
121. TOUIJER K , Kuroiwa K, Eastham JA, Vickers A, et al
     Risk-adjusted analysis of positive surgical margins following laparoscopic and retropubic radical prostatectomy.
     Eur Urol. 2007;52:1090-6.
     PubMed     Related articles    Abstract available
     
     
     
122. BERGE V , Thompson T, Blackman D
     Additional surgical intervention after radical prostatectomy, radiation therapy, androgen-deprivation therapy, or watchful waiting.
     Eur Urol. 2007;52:1036-43.
     PubMed     Related articles    Abstract available
     
     
     September 2007
123. MATTEI A , Studer UE
     Rebuttal from Authors re: Gunter Janetschek. Radioisotope-guided Lymph Node Dissection for Prostate Cancer: Potential and Limitations. Eur Urol. In press. doi:10.1016/j.eururo.2007.09.016, and Eric A. Klein, Michael Kattan, Andrew Stephenson and Andrew V
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
124. HEIDENREICH A , Aus G, Bolla M, Joniau S, et al
     EAU Guidelines on Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
125. JANETSCHEK G
     Radioisotope-Guided Lymph Node Dissection for Prostate Cancer: Potential and Limitations.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
126. EGAWA S
     Editorial Comment on: PSA in the New Millennium: A Powerful Predictor of Prostate Cancer Prognosis and Radical Prostatectomy Outcomes - Results from the SEARCH Database.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
127. JONES JS
     Prostate Cancer: Are We Over-Diagnosing-or Under-Thinking?
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
128. BARTOLETTI R
     Editorial Comment on: PSA in the New Millennium: A Powerful Predictor of Prostate Cancer Prognosis and Radical Prostatectomy Outcomes - Results from the SEARCH Database.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
129. SCHRODER FH
     Words of wisdom. Re: detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.
     Eur Urol. 2007;52:922.
     PubMed     Related articles   
     
     
     
130. SCHRODER FH , Roobol MJ
     Words of wisdom. Re: prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years.
     Eur Urol. 2007;52:921.
     PubMed     Related articles   
     
     
     
131. KIEMENEY LA
     Words of wisdom. Re: genome-wide association study of prostate cancer identifies a second risk locus at 8q24.
     Eur Urol. 2007;52:920-1.
     PubMed     Related articles   
     
     
     
132. ITO K
     Editorial comment: factor that influence serum prostate-specific antigen levels in terms of maintaining quality within a PSA screening system.
     Eur Urol. 2007;52:714.
     PubMed     Related articles   
     
     
     
133. DAMIANO R , Di Lorenzo G, Cantiello F, De Sio M, et al
     Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis.
     Eur Urol. 2007;52:648-57.
     PubMed     Related articles    Abstract available
     
     
     
134. STOCKLE M
     Editorial comment on: tension and energy-free robotic-assisted laparoscopic radical prostatectomy with interfascial dissection of the neurovascular bundle.
     Eur Urol. 2007;52:694-5.
     PubMed     Related articles   
     
     
     
135. MATTEI A , Naspro R, Annino F, Burke D, et al
     Tension and energy-free robotic-assisted laparoscopic radical prostatectomy with interfascial dissection of the neurovascular bundles.
     Eur Urol. 2007;52:687-94.
     PubMed     Related articles    Abstract available
     
     
     
136. PUPPO P
     Repeated negative prostate biopsies with persistently elevated or rising PSA: a modern urologic dilemma.
     Eur Urol. 2007;52:639-41.
     PubMed     Related articles   
     
     
     
137. MULHALL J
     Can penile size be preserved after radical prostatectomy?
     Eur Urol. 2007;52:626-8.
     PubMed     Related articles   
     
     
     
138. BRIGANTI A , Fabbri F, Salonia A, Gallina A, et al
     Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy.
     Eur Urol. 2007;52:702-7.
     PubMed     Related articles    Abstract available
     
     
     
139. YAMAMOTO S , Yonese J, Kawakami S, Ohkubo Y, et al
     Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy.
     Eur Urol. 2007;52:696-701.
     PubMed     Related articles    Abstract available
     
     
     
140. TRPKOV K
     Editorial comment on: systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
     Eur Urol. 2007;52:743-4.
     PubMed     Related articles   
     
     
     
141. BRIGANTI A , Chun FK, Hutterer GC, Gallina A, et al
     Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
     Eur Urol. 2007;52:733-43.
     PubMed     Related articles    Abstract available
     
     
     
142. GREENE DR
     Editorial comment on: systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
     Eur Urol. 2007;52:744-5.
     PubMed     Related articles   
     
     
     
143. MOTTRIE A , Van Migem P, De Naeyer G, Schatteman P, et al
     Robot-assisted laparoscopic radical prostatectomy: oncologic and functional results of 184 cases.
     Eur Urol. 2007;52:746-50.
     PubMed     Related articles    Abstract available
     
     
     
144. ARTIBANI W
     Editorial comment on: robot-assisted laparoscopic radical prostatectomy: oncologic and functional results of 184 cases.
     Eur Urol. 2007;52:750-1.
     PubMed     Related articles   
     
     
     
145. SALAMA G , Noirot O, Bataille V, Malavaud S, et al
     Seasonality of serum prostate-specific antigen levels: a population-based study.
     Eur Urol. 2007;52:708-14.
     PubMed     Related articles    Abstract available
     
     
     
146. HUBNER WA , Schlarp OM
     Adjustable continence therapy (ProACT): evolution of the surgical technique and comparison of the original 50 patients with the most recent 50 patients at a single centre.
     Eur Urol. 2007;52:680-6.
     PubMed     Related articles    Abstract available
     
     
     August 2007
147. FREEDLAND SJ , Hotaling JM, Fitzsimons NJ, Presti JC Jr, et al
     PSA in the New Millennium: A Powerful Predictor of Prostate Cancer Prognosis and Radical Prostatectomy Outcomes - Results from the SEARCH Database.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
148. COLLETTE L
     Prostate-Specific Antigen (PSA) as a Surrogate End Point for Survival in Prostate Cancer Clinical Trials.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
149. BRYANT RJ , Hamdy FC
     Screening for Prostate Cancer: An Update.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
150. KARAKIEWICZ PI
     Editorial Comment on: Laparoscopic Extended Pelvic Lymph Node Dissection for Prostate Cancer: Description of the Surgical Technique and Initial Results.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
151. BIANCO FJ JR
     Editorial Comment on: Laparoscopic Extended Pelvic Lymph Node Dissection for Prostate Cancer: Description of the Surgical Technique and Initial Results.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
152. RIBEIRO FR , Teixeira MR
     Reply to AnnaMaria Cianciulli, Roberta Merola and Costantino Leonardo's Letter to the Editor re: Franclim R. Ribeiro, Rui Henrique, Ana T. Martins, Carmen Jeronimo, Manuel R. Teixeira. Relative Copy Number Gain of MYC in Diagnostic Needle Biopsies is an
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
153. BJARTELL A
     PSA and Prostate Cancer Screening: The Challenge of the New Millennium.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
154. BRIGANTI A
     Role of hK2 in Predicting Clinically Insignificant Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
155. CIANCIULLI A , Merola R, Leonardo C
     Re: Franclim R. Ribeiro, Rui Henrique, Ana T. Martins, Carmen Jeronimo and Manuel R. Teixeira. Relative Copy Number Gain of MYC in Diagnostic Needle Biopsies is an Independent Prognostic Factor for Prostate Cancer Patients. Eur Urol 2007;52:116-25.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
156. SCATTONI V , Zlotta A, Montironi R, Schulman C, et al
     Extended and Saturation Prostatic Biopsy in the Diagnosis and Characterisation of Prostate Cancer: A Critical Analysis of the Literature.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
157. MIKUZ G , Algaba F, Beltran AL, Montironi R, et al
     Prostate Carcinoma: Atrophy or Not Atrophy That is the Question.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
158. GILLING PJ
     Prostate Cancer Following BPH Treatments: What the Patient Should Know.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
159. JOCHAM D
     Words of wisdom. Re: Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer.
     Eur Urol. 2007;52:609-10.
     PubMed     Related articles   
     
     
     
160. THALMANN GN
     Words of wisdom. Re: Detection of occult lymph node metastases in locally advanced node-negative prostate cancer.
     Eur Urol. 2007;52:608-9.
     PubMed     Related articles   
     
     
     
161. ANDRIOLE GL
     Words of wisdom. Re: Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.
     Eur Urol. 2007;52:608.
     PubMed     Related articles   
     
     
     
162. TANEJA SS
     Words of wisdom. Re: Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening.
     Eur Urol. 2007;52:607.
     PubMed     Related articles   
     
     
     
163. YOSSEPOWITCH O
     This paper evaluates the natural history of prostate cancer in heterogeneous cohort of men treated with HT.
     Eur Urol. 2007;52:453.
     PubMed     Related articles   
     
     
     
164. LOTAN Y
     Despite PSA screening and the control by radical prostatectomy, patients treatment fails and have a PSA recurrence.
     Eur Urol. 2007;52:453-4.
     PubMed     Related articles   
     
     
     
165. DE LA TAILLE A
     Over the past decade, prostate needle biopsies have been studied widely.
     Eur Urol. 2007;52:444-5.
     PubMed     Related articles   
     
     
     
166. OYAMA N
     Editorial comment on: Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
     Eur Urol. 2007;52:429.
     PubMed     Related articles   
     
     
     
167. SCATTONI V , Picchio M, Suardi N, Messa C, et al
     Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
     Eur Urol. 2007;52:423-9.
     PubMed     Related articles    Abstract available
     
     
     
168. SCHODER H , Bochner B
     Detection and management of isolated lymph node recurrence in patients with PSA relapse.
     Eur Urol. 2007;52:310-2.
     PubMed     Related articles   
     
     
     
169. WALDKIRCH ES , Uckert S, Langnase K, Richter K, et al
     Immunohistochemical distribution of cyclic GMP-dependent protein kinase-1 in human prostate tissue.
     Eur Urol. 2007;52:495-501.
     PubMed     Related articles    Abstract available
     
     
     
170. AZADZOI KM
     Editorial comment on: Immunohistochemical distribution of cyclic GMP-dependent protein kinase-1 in human prostate tissue.
     Eur Urol. 2007;52:501-2.
     PubMed     Related articles   
     
     
     
171. KELLER H , Lehmann J, Beier J
     Radical perineal prostatectomy and simultaneous extended pelvic lymph node dissection via the same incision.
     Eur Urol. 2007;52:384-8.
     PubMed     Related articles    Abstract available
     
     
     
172. CHUN FK , Briganti A, Graefen M, Montorsi F, et al
     Development and external validation of an extended 10-core biopsy nomogram.
     Eur Urol. 2007;52:436-44.
     PubMed     Related articles    Abstract available
     
     
     July 2007
173. VAN DER POEL HG
     Editorial Comment on: Oncological and Functional Results of Antegrade Radical Retropubic Prostatectomy for the Treatment of Clinically Localised Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
174. TURKERI L
     Editorial Comment on: Oncological and Functional Results of Antegrade Radical Retropubic Prostatectomy for the Treatment of Clinically Localised Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
175. GANZER R , Rogenhofer S, Walter B, Lunz JC, et al
     PSA Nadir Is a Significant Predictor of Treatment Failure after High-Intensity Focussed Ultrasound (HIFU) Treatment of Localised Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
176. CARINI M , Masieri L, Minervini A, Lapini A, et al
     Oncological and Functional Results of Antegrade Radical Retropubic Prostatectomy for the Treatment of Clinically Localised Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
177. BOSTROM PJ , Soloway MS
     Secondary Cancer After Radiotherapy for Prostate Cancer: Should We Be More Aware of the Risk?
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
178. BADALYAN R
     Editorial Comment on: Erectile Function in Prostate Cancer-Free Patients Who Underwent Prostate Saturation Biopsy.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
179. TRUSS MC
     Editorial Comment on: Erectile Function in Prostate Cancer-Free Patients Who Underwent Prostate Saturation Biopsy.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
180. JONIAU S
     Editorial Comment on: Predictive Factors for Progression in Patients with Clinical Stage T1a Prostate Cancer in the PSA Era.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
181. SCATTONI V
     Editorial Comment on: Predictive Factors for Progression in Patients with Clinical Stage T1a Prostate Cancer in the PSA Era.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
182. AKBAL C , Turker P, Tavukcu HH, Simsek F, et al
     Erectile Function in Prostate Cancer-Free Patients Who Underwent Prostate Saturation Biopsy.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
183. VAN LEENDERS G
     Despite extensive efforts, the validation of prognostic tissue markers in prostate cancer has not yet resulted in the widespread implementation of novel diagnostic tests.
     Eur Urol. 2007;52:125.
     PubMed     Related articles   
     
     
     
184. ARTIBANI W , Ficarra V, Guillonneau BD
     Open to debate. The motion: a robot is needed to perform the best nerve sparing prostatectomy.
     Eur Urol. 2007;52:275-8.
     PubMed     Related articles   
     
     
     
185. GILBERT SM
     Reliable measurement in urology: room for improvement.
     Eur Urol. 2007;52:1-2.
     PubMed     Related articles   
     
     
     
186. HEIDENREICH A , Ohlmann CH, Polyakov S
     Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.
     Eur Urol. 2007;52:29-37.
     PubMed     Related articles    Abstract available
     
     
     
187. GALLINA A , Chun FK, Briganti A, Shariat SF, et al
     Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.
     Eur Urol. 2007;52:98-105.
     PubMed     Related articles    Abstract available
     
     
     
188. WECKERMANN D
     Editorial comment on: Detection rate and operating time required for gamma probe-guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging.
     Eur Urol. 2007;52:132-3.
     PubMed     Related articles   
     
     
     
189. DI LORENZO G , Autorino R
     Bicalutamide-induced gynaecomastia: do we have the answer?
     Eur Urol. 2007;52:5-8.
     PubMed     Related articles   
     
     
     
190. WARNCKE SH , Mattei A, Fuechsel FG, Z'Brun S, et al
     Detection rate and operating time required for gamma probe-guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging.
     Eur Urol. 2007;52:126-32.
     PubMed     Related articles    Abstract available
     
     
     
191. ATES M , Teber D, Gozen AS, Tefekli A, et al
     A new postoperative predictor of time to urinary continence after laparoscopic radical prostatectomy: the urine loss ratio.
     Eur Urol. 2007;52:178-85.
     PubMed     Related articles    Abstract available
     
     
     
192. BARRE C
     Open radical retropubic prostatectomy.
     Eur Urol. 2007;52:71-80.
     PubMed     Related articles    Abstract available
     
     
     
193. LLOYD SN , Tirukonda P, Biyani CS, Wah TM, et al
     The detour extra-anatomic stent--a permanent solution for benign and malignant ureteric obstruction?
     Eur Urol. 2007;52:193-8.
     PubMed     Related articles    Abstract available
     
     
     
194. HARDING C , Robson W, Drinnan M, Sajeel M, et al
     Predicting the outcome of prostatectomy using noninvasive bladder pressure and urine flow measurements.
     Eur Urol. 2007;52:186-92.
     PubMed     Related articles    Abstract available
     
     
     
195. HARRIS MJ
     The anatomic radical perineal prostatectomy: an outcomes-based evolution.
     Eur Urol. 2007;52:81-8.
     PubMed     Related articles    Abstract available
     
     
     June 2007
196. CHUN FK , Graefen M, Suardi N, Karakiewicz PI, et al
     Reply to Ian Beckley and Masood A. Khan's Letter to the Editor re: Felix K.-H. Chun, Thomas Steuber, Andreas Erbersdobler et al. Development and Internal Validation of a Nomogram Predicting the Probability of Prostate Cancer Gleason Sum Upgrading Between
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
197. BECKLEY I , Khan MA
     Re: Felix K.-H. Chun, Thomas Steuber, Andreas Erbersdobler, et al. Development and Internal Validation of a Nomogram Predicting the Probability of Prostate Cancer Gleason Sum Upgrading Between Biopsy and Radical Prostatectomy Pathology. Eur Urol 2006;49:
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
198. DESCAZEAUD A , Peyromaure M, Salin A, Amsellem-Ouazana D, et al
     Predictive Factors for Progression in Patients with Clinical Stage T1a Prostate Cancer in the PSA Era.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
199. RABIEN A , Jung M, Fritzsche F, Erguen B, et al
     Reply to Chitranjan J. Shukla, Dylan Edwards and Krishna K. Sethia's Letter to the Editor re: Anja Rabien, Mick Burkhardt, Monika Jung, Florian Fritzsche, Martin Ringsdorf, Hanka Schicktanz, Stefan A. Loening, Glen Kristiansen and Klaus Jung. Decreased R
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
200. SHUKLA CJ , Edwards D, Sethia KK
     Re: Anja Rabien, Mick Burkhardt, Monika Jung, Florian Fritzsche, Martin Ringsdorf, Hanka Schicktanz, Stefan A. Loening, Glen Kristiansen and Klaus Jung. Decreased RECK Expression Indicating Proteolytic Imbalance in Prostate Cancer is Associated with High
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
201. VIS AN , Roemeling S, Reedijk AM, Otto SJ, et al
     Overall Survival in the Intervention Arm of a Randomized Controlled Screening Trial for Prostate Cancer Compared with a Clinically Diagnosed Cohort.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
202. SECIN FP , Jiborn T, Bjartell AS, Fournier G, et al
     Multi-institutional Study of Symptomatic Deep Venous Thrombosis and Pulmonary Embolism in Prostate Cancer Patients Undergoing Laparoscopic or Robot-Assisted Laparoscopic Radical Prostatectomy.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
203. HAKENBERG OW
     Editorial Comment on: Local Progression among Men with Conservatively Treated Localized Prostate Cancer: Results from the Transatlantic Prostate Group.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
204. BRIGANTI A , Karakiewicz PI, Chun FK, Gallina A, et al
     Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection.
     Eur Urol. 2007;51:1573-81.
     PubMed     Related articles    Abstract available
     
     
     
205. FILOCAMO MT , Li Marzi V, Del Popolo G, Cecconi F, et al
     Pharmacologic treatment in postprostatectomy stress urinary incontinence.
     Eur Urol. 2007;51:1559-64.
     PubMed     Related articles    Abstract available
     
     
     May 2007
206. EASTHAM JA , Kattan MW, Fearn P, Fisher G, et al
     Local Progression among Men with Conservatively Treated Localized Prostate Cancer: Results from the Transatlantic Prostate Group.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
207. VAN DEN BERGH RC , Roemeling S, Roobol MJ, Roobol W, et al
     Prospective Validation of Active Surveillance in Prostate Cancer: The PRIAS Study.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
208. BUSCHEMEYER WC 3RD , Freedland SJ
     Obesity and Prostate Cancer: Epidemiology and Clinical Implications.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
209. LATTOUF JB , Beri A, Jeschke S, Sega W, et al
     Laparoscopic Extended Pelvic Lymph Node Dissection for Prostate Cancer: Description of the Surgical Technique and Initial Results.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
210. SCHRODER FH
     Re: Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
     Eur Urol. 2007;51:1443-4.
     PubMed     Related articles   
     
     
     
211. SCHENK-BRAAT EA
     Re: Five-year follow-up of replication-competent adenovirus-mediated suicide gene therapy for treatment of prostate cancer.
     Eur Urol. 2007;51:1442-3.
     PubMed     Related articles   
     
     
     
212. ROOBOL MJ
     Re: Longitudinal PSA changes in men with and without prostate cancer: assessment of prostate cancer risk.
     Eur Urol. 2007;51:1441-2.
     PubMed     Related articles   
     
     
     
213. BANGMA CH
     Re: Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured as age 44 to 50 years.
     Eur Urol. 2007;51:1439-40.
     PubMed     Related articles   
     
     
     
214. AUS G
     Second-line therapy after radical prostatectomy failure: for whom? When? How?
     Eur Urol. 2007;51:1155-7.
     PubMed     Related articles   
     
     
     
215. SIMMONS MN , Stephenson AJ, Klein EA
     Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy.
     Eur Urol. 2007;51:1175-84.
     PubMed     Related articles    Abstract available
     
     
     
216. TOMBAL B
     Docetaxel and beyond.
     Eur Urol. 2007;51:1159-61.
     PubMed     Related articles   
     
     
     
217. ROEMELING S , Roobol MJ, de Vries SH, Wolters T, et al
     Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome.
     Eur Urol. 2007;51:1244-50.
     PubMed     Related articles    Abstract available
     
     
     
218. STEPHAN C , Meyer HA, Cammann H, Lein M, et al
     Re: Felix K.-H. Chun, Markus Graefen, Alberto Briganti, Andrea Gallina, Julia Hopp, Michael W. Kattan, Hartwig Huland and Pierre I. Karakiewicz. Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus art
     Eur Urol. 2007;51:1446-7.
     PubMed     Related articles   
     
     
     
219. SECIN FP , Touijer K, Mulhall J, Guillonneau B, et al
     Anatomy and preservation of accessory pudendal arteries in laparoscopic radical prostatectomy.
     Eur Urol. 2007;51:1229-35.
     PubMed     Related articles    Abstract available
     
     
     
220. CHUN FK , Graefen M, Briganti A, Gallina A, et al
     Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.
     Eur Urol. 2007;51:1236-40.
     PubMed     Related articles    Abstract available
     
     
     April 2007
221. KARAKIEWICZ PI
     Editorial Comment on: Prostate Cancer Characteristics in a Multiracial Community.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
222. CHUN FK
     Editorial Comment on: Prostate Cancer Characteristics in a Multiracial Community.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
223. KJELLMAN A , Akre O, Norming U, Tornblom M, et al
     Dihydrotestosterone Levels and Survival in Screening-Detected Prostate Cancer: A 15-yr Follow-up Study.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
224. RAVERY V , Dominique S, Hupertan V, Ben Rhouma S, et al
     Prostate Cancer Characteristics in a Multiracial Community.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
225. CLARKE NW , Brown MD
     The Influence of Lipid Metabolism on Prostate Cancer Development and Progression: Is it Time for a Closer Look?
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
226. RAAIJMAKERS R , de Vries SH, Blijenberg BG, Wildhagen MF, et al
     hK2 and Free PSA, a Prognostic Combination in Predicting Minimal Prostate Cancer in Screen-Detected Men within the PSA Range 4-10 ng/ml.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
227. PRAYER-GALETTI T
     Editorial Comment on: Low-Activity V89L Variant in SRD5A2 Is Associated with Aggressive Prostate Cancer Risk: An Explanation for the Adverse Effects Observed in Chemoprevention Trials Using 5-Alpha-Reductase Inhibitors.
     Eur Urol. 2007;.